We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Personal ECG Provides Multi-Dimensional Cardiac Insights

By HospiMedica International staff writers
Posted on 20 May 2019
An innovative six-lead electrocardiogram (ECG) device provides patients and their physicians with the ability to detect a broad range of cardiac conditions.

The AliveCor (San Francisco, CA, USA) KardiaMobile 6L is a ground-braking six-lead personal ECG device that can provide a detailed view into patients' hearts, including detection of various arrhythmias that are leading indicators of cardiovascular disease (CVD). More...
Consistent in design with the existing KardiaMobile personal ECG, the 6L sports an extra electrode on the bottom of the device, in addition to the two electrodes set on top. Users place their thumbs on each of the topside electrodes and the bottom electrode on the left knee or the ankle.

This formation, known as the Einthoven Triangle, forms a three-way relationship of ECG leads across the limbs, placing the heart at the center, thus allowing cardiologists to view the electrical activity of the heart from six different perspectives (ECG leads I, II, II, aVL, aVR, and aVF). As a result, the 6L can detect atrial fibrillation (AF), bradycardia, tachycardia, as well as normal heart rhythm, over a period of just 30 seconds. In order to view the ECG, KardiaMobile 6L is paired via Bluetooth with a smartphone or tablet device, and the data is sent to the Kardia app for instant analysis.

“KardiaMobile 6L is the most clinically valuable personal ECG ever created, and another significant step in AliveCor's march to making heart care more convenient, more accessible, and less expensive than ever before,” said Ira Bahr, CEO of AliveCor.

AF occurs when the heart's two upper chambers beat erratically. In one form, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. AF can lead to serious adverse events such as thrombi traveling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.